Insider · CIK 0001252524

Emster Kurt VON

CIK 0001252524 Name as filed on the most recent filing

Filed as Emster Kurt VON (60)

97 transaction lines · from 60 filings · filed 2004-02-23 to 2023-09-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

96 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-09-29 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 249,675, disposed Open Form 4 filing 0001062993-23-018622
2023-04-13 S, Open-market sale Jasper Therapeutics, Inc.JSPR 13,524, disposed Open Form 4 filing 0001213900-23-029900
2021-05-18 P, Open-market purchase Vera Therapeutics, Inc.VERA 8,499,997, acquired Open Form 4 filing 0001209191-21-033806
2021-05-17 P, Open-market purchase Vera Therapeutics, Inc.VERA 214,656, acquired Open Form 4 filing 0001209191-21-033806
2020-06-16 P, Open-market purchase Vaxcyte, Inc.PCVX 200,000, acquired Open Form 4 filing 0000905718-20-000595
2018-12-18 S, Open-market sale Crispr Therapeutics AGCRSP 1,869,168, disposed Open Form 4 filing 0000905718-19-000065
2018-12-18 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 397,365, disposed Open Form 4 filing 0000905718-18-000979
2018-12-18 S, Open-market sale Crispr Therapeutics AGCRSP 2,077,101, disposed Open Form 4 filing 0000905718-18-000981
2018-12-17 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 726,223, disposed Open Form 4 filing 0000905718-18-000979
2018-12-17 S, Open-market sale Crispr Therapeutics AGCRSP 99,797, disposed Open Form 4 filing 0000905718-18-000981
2018-06-05 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 11,509, disposed Open Form 4 filing 0000905718-18-000561
2018-06-05 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 11,509, disposed Open Form 4 filing 0000905718-18-000559
2018-06-05 S, Open-market sale Crispr Therapeutics AGCRSP 11,509, disposed Open Form 4 filing 0000905718-18-000554
2018-05-14 S, Open-market sale Crispr Therapeutics AGCRSP 6 lines 22,142,556, disposed Open Form 4 filing 0000905718-18-000518
2018-05-11 S, Open-market sale Crispr Therapeutics AGCRSP 3 lines 13,209,900, disposed Open Form 4 filing 0000905718-18-000518
2018-03-05 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 207,105, disposed Open Form 4 filing 0000905718-18-000307
2018-02-15 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 995,637, disposed Open Form 4 filing 0000905718-18-000263
2018-02-14 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 2,231,183, disposed Open Form 4 filing 0000905718-18-000260
2018-02-14 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 2,720,120, disposed Open Form 4 filing 0000905718-18-000256
2018-02-13 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 744,104, disposed Open Form 4 filing 0000905718-18-000256
2018-02-07 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 503,423, disposed Open Form 4 filing 0000905718-18-000117
2018-02-05 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 228,608, disposed Open Form 4 filing 0000905718-18-000115
2018-02-02 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 24,220, disposed Open Form 4 filing 0000905718-18-000111
2018-02-01 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 1,070,391, disposed Open Form 4 filing 0000905718-18-000111
2018-01-31 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 150,429, disposed Open Form 4 filing 0000905718-18-000096
2018-01-30 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 1,042,843, disposed Open Form 4 filing 0000905718-18-000096
2018-01-25 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 480,355, disposed Open Form 4 filing 0000905718-18-000074
2018-01-22 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 1,437,831, disposed Open Form 4 filing 0000905718-18-000070
2018-01-19 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 1,338,486, disposed Open Form 4 filing 0000905718-18-000064
2018-01-18 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 139,183, disposed Open Form 4 filing 0000905718-18-000064
2018-01-05 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 43,903, disposed Open Form 4 filing 0000905718-18-000045
2018-01-05 P, Open-market purchase Crispr Therapeutics AGCRSP 1,499,999, acquired Open Form 4 filing 0000905718-18-000054
2018-01-05 S, Open-market sale Crispr Therapeutics AGCRSP 2,489,406, disposed Open Form 4 filing 0000905718-18-000047
2018-01-02 S, Open-market sale Crispr Therapeutics AGCRSP 1,010,123, disposed Open Form 4 filing 0000905718-18-000020
2017-12-22 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 1,629,304, disposed Open Form 4 filing 0000905718-17-001042
2017-11-10 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 463,379, disposed Open Form 4 filing 0000905718-17-000974
2017-11-01 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 39,979, disposed Open Form 4 filing 0000905718-17-000942
2017-10-31 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 487,352, disposed Open Form 4 filing 0000905718-17-000938
2017-10-30 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 61,449, disposed Open Form 4 filing 0000905718-17-000938
2017-10-03 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 554,041, disposed Open Form 4 filing 0000905718-17-000867
2017-10-02 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 300,832, disposed Open Form 4 filing 0000905718-17-000867
2017-09-29 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 970,709, disposed Open Form 4 filing 0000905718-17-000853
2017-09-28 S, Open-market sale CymaBay Therapeutics, Inc.CBAY 736,670, disposed Open Form 4 filing 0000905718-17-000853

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 8
  • Open-market sale 88
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. EMSTER KURT VON, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001252524

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.